Sun Pharmaceutical Industries Ltd. closed 9.91% short of its 52-week high of 1,960.20 rupees, which the company reached on ...
Shares of Sun Pharmaceutical Industries Ltd. 524715 inched up 0.08% to 1,785.30 Indian rupees Monday, on what proved to be an ...
3d
TipRanks on MSNUnited Laboratories’ Liraglutide Injection Gains NMPA ApprovalThe United Laboratories International Holdings ( ($HK:3933) ) has issued an update. The United Laboratories International Holdings Limited ...
Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...
Previously, Rybelsus — an approved diabetes drug in pill form — was also used for weight loss by patients in India. Launched ...
The share price of Sun Pharmaceuticals Industries (Sun Pharma) is shining bright, the top gainer in intra-day trade, up 3%. This surge in the share price came after the company announced an ...
The stock of the country’s largest pharmaceutical company, Sun Pharmaceutical Industries (Sun Pharma), has shed about 15 per cent from its highs over the last three months. Weak US sales trajectory, ...
Sun Pharmaceutical Industries has agreed to acquire US-based cancer drug maker in a deal valued at $355 million in upfront cash payment, India’s biggest pharma company said in a press release ...
Sun Pharma, India's largest pharmaceutical company, is set to acquire Checkpoint Therapeutics for $355 million. This strategic acquisition will enhance Sun Pharma's specialty portfolio ...
Sun Pharma (Sun) is acquiring US-based early-stage oncology-focused biotech company Checkpoint Therapeutics (Checkpoint) for an upfront cash payment of USD 4.1/share (total outgo of USD 355mn ...
Sun Pharma share price today reached ₹1,651.80, a 2.50% rise from its last close of ₹1,611.50. The rise is despite the overall market downtrend, highlighting Sun Pharma's strength in the pharma ...
Sun Pharmaceutical Industries has agreed to acquire Checkpoint Therapeutics, Inc. for $4.10 per share, a 65% premium to last traded price, post-FDA approval of Unloxcyt for metastatic cutaneous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results